Costas Tsatalas

1.1k total citations
37 papers, 739 citations indexed

About

Costas Tsatalas is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Costas Tsatalas has authored 37 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 18 papers in Genetics and 10 papers in Immunology. Recurrent topics in Costas Tsatalas's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Costas Tsatalas is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Costas Tsatalas collaborates with scholars based in Greece, United Kingdom and Cyprus. Costas Tsatalas's co-authors include Ιoannis Kotsianidis, Emmanouil Spanoudakis, E. C. Gordon‐Smith, Dimitrios Margaritis, G Hale, Lydia Jones, Irene Bouchliou, Jill Hows, A. W. G. Goolden and Jane F. Apperley and has published in prestigious journals such as Blood, American Journal of Respiratory and Critical Care Medicine and Annals of Oncology.

In The Last Decade

Costas Tsatalas

36 papers receiving 726 citations

Peers

Countries citing papers authored by Costas Tsatalas

Since Specialization

Citations

This map shows the geographic impact of Costas Tsatalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costas Tsatalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costas Tsatalas more than expected).

Fields of papers citing papers by Costas Tsatalas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costas Tsatalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costas Tsatalas. The network helps show where Costas Tsatalas may publish in the future.

Co-authorship network of co-authors of Costas Tsatalas

This figure shows the co-authorship network connecting the top 25 collaborators of Costas Tsatalas. A scholar is included among the top collaborators of Costas Tsatalas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costas Tsatalas. Costas Tsatalas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Paroxysmal nocturnal haemoglobinuria, lupus and pregnancy 2013 ·Journal of Obstetrics and Gynaecology ·Emmanuel N. Kontomanolis, Aikaterini Arvaniti, Anna Christoforidou, Dimitrios Margaritis, Costas Tsatalas, Nikoleta Koutlaki, Maria Samakouri, Γεώργιος Γαλάζιος, (unknown)	2
2	Has introduction of azacytidine in everyday clinical practice improved survival in late-stage Myelodysplastic syndrome? A single center experience 2013 ·Leukemia Research ·Menelaos Papoutselis, (unknown), Vasileios Papadopoulos, Emmanouil Spanoudakis, Dimitrios Margaritis, Costas Tsatalas, Ιoannis Kotsianidis	4
3	Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment 2013 ·Leukemia Research ·(unknown), Menelaos Papoutselis, Theodoros P. Vassilakopoulos, Vasileios Papadopoulos, Emmanouil Spanoudakis, Costas Tsatalas, Ιoannis Kotsianidis	9
4	Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2<sup>V617F</sup> Mutation Status 2011 ·Acta Haematologica ·(unknown), Costas Tsatalas, Konstantinos Anagnostopoulos, Grigorios Trypsianis, (unknown), (unknown), (unknown), Emmanouil Spanoudakis, Ιoannis Kotsianidis, Dimitrios Margaritis, Alexandros Kortsaris, George Bourikas	4
5	The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function 2011 ·Annals of Oncology ·Meletios Α. Dimopoulos, Efstathios Kastritis, Eurydiki Michalis, Costas Tsatalas, Michalis Michael, Anastasia Pouli, Zafiris Kartasis, Sosana Delimpasi, Dimitra Gika, Athanasios Zomas, Μαρία Ρούσσου, (unknown), Agapi Parcharidou, Konstantinos Zervas, Evangelos Terpos	19
6	Th17 and Foxp3+ T regulatory cell dynamics and distribution in myelodysplastic syndromes 2011 ·Clinical Immunology ·Irene Bouchliou, (unknown), Evangelia Nakou, Emmanouil Spanoudakis, (unknown), Sofia Vakalopoulou, (unknown), (unknown), George Bourikas, Costas Tsatalas, Ιoannis Kotsianidis	42
7	Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis 2009 ·American Journal of Respiratory and Critical Care Medicine ·Ιoannis Kotsianidis, Evangelia Nakou, Irene Bouchliou, Argyrios Tzouvelekis, Emmanouil Spanoudakis, Paschalis Steiropoulos, Ioannis Sotiriou, Vassilis Aidinis, Dimitrios Margaritis, Costas Tsatalas, Demosthenes Bouros	177
8	Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders 2009 ·Current Stem Cell Research & Therapy ·Emmanouil Spanoudakis, Costas Tsatalas	3
9	Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation 2008 ·Leukemia Research ·Emmanouil Spanoudakis, Dimitrios Margaritis, Ιoannis Kotsianidis, George Georgiou, G. Tripsianis, (unknown), (unknown), (unknown), Panayiotis Panayiotidis, George Bourikas, Costas Tsatalas	1
10	In vitro Effects of the Farnesyltransferase Inhibitor Tipifarnib on Myelodysplastic Syndrome Progenitors 2008 ·Acta Haematologica ·Ιoannis Kotsianidis, (unknown), (unknown), Emmanouil Spanoudakis, (unknown), Dimitrios Margaritis, George Bourikas, R. De Coster, Peter De Porre, Costas Tsatalas	2
11	Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV) patients 2008 ·Annals of Hematology ·Emmanouil Spanoudakis, (unknown), Ιoannis Kotsianidis, Dimitrios Margaritis, (unknown), Anna Christoforidou, Costas Tsatalas, George Bourikas	13
12	Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy 2008 ·Acta Haematologica ·Anna Christoforidou, (unknown), (unknown), (unknown), Dimitrios Margaritis, Ιoannis Kotsianidis, (unknown), V. Kaloutsi, George Bourikas, Costas Tsatalas	12
13	Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells 2005 ·Blood ·Ιoannis Kotsianidis, Jonathan D. Silk, Emmanouil Spanoudakis, Scott D. Patterson, António Almeida, Richard R. Schmidt, Costas Tsatalas, George Bourikas, Vincenzo Cerundolo, Irene Roberts, Anastasios Karadimitris	30
14	Amifostine Stimulates the Formation of Hematopoietic Bone Marrow Progenitors from B-Cell Chronic Lymphocytic Leukemia 2004 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), (unknown), Ιoannis Kotsianidis, (unknown), Gregory Tripsianis, (unknown), Zafiris Kartasis, (unknown), George Bourikas	2
15	Long‐term remission of recalcitrant tumour‐stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin 2003 ·Journal of the European Academy of Dermatology and Venereology ·Costas Tsatalas, (unknown), Dimitrios Margaritis, (unknown), Ιoannis Kotsianidis, (unknown), (unknown)	4
16	Splenectomy for Massive Splenic Infarction Unmasks Paroxysmal Nocturnal Hemoglobinuria 2003 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), Ιoannis Kotsianidis, Anastasios J. Karayiannakis, (unknown), Zafiris Kartasis, (unknown), Alexandros Polychronidis, (unknown), George Bourikas	10
17	Efficacy of Lamivudine in Patients with Hematologic Malignancies Receiving Chemotherapy and Precore Mutant Chronic Active Hepatitis B 2002 ·Acta Haematologica ·(unknown), Costas Tsatalas, (unknown), (unknown), (unknown), Stamatia Kotsiou, G Kartalis, George Bourikas	9
18	Successful Treatment of Angioimmunoblastic Lymphadenopathy with Dysproteinemia-Type T-Cell Lymphoma with Fludarabine 2001 ·Acta Haematologica ·Costas Tsatalas, (unknown), (unknown), (unknown), Ιoannis Kotsianidis, George Bourikas	15
19	Transfusion-dependent homozygous β-thalassaemia major: successful pregnancy in five cases 1997 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), Costas Tsatalas, (unknown), (unknown), John Christakis, (unknown), (unknown)	23
20	Increased peripheral blood normal myeloid progenitor cells (CFU‐GM) in chronic lymphocytic leukemia: A perspective for autologous peripheral blood stem cell transplantation 1995 ·European Journal Of Haematology ·Costas Tsatalas, (unknown), (unknown), Ioannis Venizelos, (unknown), Theodotis Papageorgiou, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact